Scinai Immunotherapeutics Secures $5.1M in CDMO Work, Extends Runway to Late 2027
Scinai announced about $5.1 million in committed CDMO services and about $5.3 million in net financing proceeds. It estimates its operating runway will extend to late 2027, with potential extension into Q3 2028 if later project phases are activated.
Scinai Immunotherapeutics Ltd. announced ~$5.1M in committed CDMO services, ~$5.3M net financing proceeds, and an estimated operating runway to late 2027, with potential extension into Q3 2028 if later project phases are activated.Material DetailsContext by AI AnalystThis is an early-to-mid pivot t…